The immunologic tumor microenvironment in endometrioid endometrial cancer in the morphomolecular context: mutual correlations and prognostic impact depending on molecular alterationsBarbara Willvonseder, Melanie Boxberg, Jutta Engel et al.|Cancer Immunology Immunotherapy|2020Cited by 35
TP53 germline mutations in the context of families with hereditary breast and ovarian cancer: a clinical challengeSabine Grill, Anne S. Quante, Juliane Ramser et al.|Archives of Gynecology and Obstetrics|2020Cited by 8
Independent Tissue-Based Biomarkers in Endometrioid Endometrial Cancer: Tumor Budding in Microsatellite Instability and WHO Grading in Copy-Number-Low PatientsFabian Stögbauer, Melanie Boxberg, Barbara Geß et al.|Cancers|2023Cited by 5